Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
מצבים רפואיים
Graft Vs Host Disease · Graft-versus-host-disease · Graft Versus Host Disease
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Ramzi Abboud, M.D.)Camille Abboud, M.D. (Sub-investigator)Kelly Bolton, M.D. (Sub-investigator)Amanda Cashen, M.D. (Sub-investigator)Matt Christopher, M.D. (Sub-investigator)Zachary Crees, M.D. (Sub-investigator)John Dipersio, M.D., Ph.D. (Sub-investigator)Todd Fehniger, M.D., Ph.D. (Sub-investigator)Armin Ghobadi, M.D. (Sub-investigator)Meagan Jacoby, M.D., Ph.D. (Sub-investigator)Brad Kahl, M.D. (Sub-investigator)Iskra Pusic, M.D. (Sub-investigator)Mark Schroeder, M.D. (Sub-investigator)Keith Stockerl-Goldstein, M.D. (Sub-investigator)Geoffrey Uy, M.D. (Sub-investigator)Ravi Vij, M.D. (Sub-investigator)Matthew Walter, M.D. (Sub-investigator)Feng Gao, Ph.D. (Sub-investigator)
מובילי המחקר
Ramzi Abboud, M.D.
Principal Investigator
Washington University School of Medicine